FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3130217340> ?p ?o ?g. }

• W3130217340 abstract "Severe ascites is an adverse event of ramucirumab (RAM), a second‑line treatment for hepatocellular carcinoma (HCC). Ascites can be associated with various factors, including nutritional status and muscle quality. The aim of the present study was to investigate the prevalence and profiles of RAM‑associated severe ascites in patients with HCC. This retrospective study enrolled 14 consecutive patients with HCC treated with RAM (median age, 72 years; Barcelona Clinic Liver Cancer stage B/C, 6/8). Nutritional status and muscle quality were evaluated using the controlling nutritional status (CONUT) score and intramuscular adipose tissue (IMAT) content, respectively. Factors associated with severe ascites were evaluated using decision‑tree analysis. The median progression‑free survival (PFS) time was 2.1 months, and the overall objective response and disease control rates were 14 and 50%, respectively. Severe ascites developed in 57.1% of the patients, and the median onset was 37.5 days (range, 14‑61 days) after initiation of RAM treatment. In the decision‑tree analysis, the CONUT score and IMAT content were the first and second splitting variables for the development of severe ascites. In patients with a CONUT score ≥5 and IMAT <‑0.54, the prevalence of severe ascites was 80 and 100%, respectively. A high incidence of severe ascites was observed in patients treated with RAM. A CONUT score ≥5 and an IMAT <‑0.54 were associated with severe ascites. Thus, caution must be taken for severe ascites in patients with HCC treated with RAM, in particular patients with malnutrition and fat infiltration in muscle." @default.
• W3130217340 created "2021-03-01" @default.
• W3130217340 creator A5005361135 @default.
• W3130217340 creator A5006354271 @default.
• W3130217340 creator A5012513340 @default.
• W3130217340 creator A5013194037 @default.
• W3130217340 creator A5016855346 @default.
• W3130217340 creator A5021514669 @default.
• W3130217340 creator A5032488382 @default.
• W3130217340 creator A5033954465 @default.
• W3130217340 creator A5037691579 @default.
• W3130217340 creator A5044911306 @default.
• W3130217340 creator A5072088828 @default.
• W3130217340 creator A5074219274 @default.
• W3130217340 creator A5084839932 @default.
• W3130217340 creator A5086838517 @default.
• W3130217340 date "2021-02-25" @default.
• W3130217340 modified "2023-10-13" @default.
• W3130217340 title "Prevalence and profiles of ramucirumab‑associated severe ascites in patients with hepatocellular carcinoma" @default.
• W3130217340 cites W1971837077 @default.
• W3130217340 cites W1989553067 @default.
• W3130217340 cites W2002658934 @default.
• W3130217340 cites W2043583700 @default.
• W3130217340 cites W2050982567 @default.
• W3130217340 cites W2079586464 @default.
• W3130217340 cites W2083017947 @default.
• W3130217340 cites W2099540110 @default.
• W3130217340 cites W2111237964 @default.
• W3130217340 cites W2119190881 @default.
• W3130217340 cites W2121847974 @default.
• W3130217340 cites W2143049458 @default.
• W3130217340 cites W2261020375 @default.
• W3130217340 cites W2277004004 @default.
• W3130217340 cites W2338176435 @default.
• W3130217340 cites W2521441342 @default.
• W3130217340 cites W2560499218 @default.
• W3130217340 cites W2736784297 @default.
• W3130217340 cites W2761031851 @default.
• W3130217340 cites W2765834072 @default.
• W3130217340 cites W2776764280 @default.
• W3130217340 cites W2787358630 @default.
• W3130217340 cites W2802123389 @default.
• W3130217340 cites W2806846968 @default.
• W3130217340 cites W2885024987 @default.
• W3130217340 cites W2900106904 @default.
• W3130217340 cites W2908573150 @default.
• W3130217340 cites W2924060990 @default.
• W3130217340 cites W2939267996 @default.
• W3130217340 cites W2947647870 @default.
• W3130217340 cites W2984563646 @default.
• W3130217340 cites W3007189276 @default.
• W3130217340 cites W3014077135 @default.
• W3130217340 cites W3015886172 @default.
• W3130217340 cites W3016423671 @default.
• W3130217340 doi "https://doi.org/10.3892/mco.2021.2241" @default.
• W3130217340 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7947949" @default.
• W3130217340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33758660" @default.
• W3130217340 hasPublicationYear "2021" @default.
• W3130217340 type Work @default.
• W3130217340 sameAs 3130217340 @default.
• W3130217340 citedByCount "4" @default.
• W3130217340 countsByYear W31302173402021 @default.
• W3130217340 countsByYear W31302173402022 @default.
• W3130217340 countsByYear W31302173402023 @default.
• W3130217340 crossrefType "journal-article" @default.
• W3130217340 hasAuthorship W3130217340A5005361135 @default.
• W3130217340 hasAuthorship W3130217340A5006354271 @default.
• W3130217340 hasAuthorship W3130217340A5012513340 @default.
• W3130217340 hasAuthorship W3130217340A5013194037 @default.
• W3130217340 hasAuthorship W3130217340A5016855346 @default.
• W3130217340 hasAuthorship W3130217340A5021514669 @default.
• W3130217340 hasAuthorship W3130217340A5032488382 @default.
• W3130217340 hasAuthorship W3130217340A5033954465 @default.
• W3130217340 hasAuthorship W3130217340A5037691579 @default.
• W3130217340 hasAuthorship W3130217340A5044911306 @default.
• W3130217340 hasAuthorship W3130217340A5072088828 @default.
• W3130217340 hasAuthorship W3130217340A5074219274 @default.
• W3130217340 hasAuthorship W3130217340A5084839932 @default.
• W3130217340 hasAuthorship W3130217340A5086838517 @default.
• W3130217340 hasBestOaLocation W31302173401 @default.
• W3130217340 hasConcept C120665830 @default.
• W3130217340 hasConcept C121332964 @default.
• W3130217340 hasConcept C121608353 @default.
• W3130217340 hasConcept C126322002 @default.
• W3130217340 hasConcept C2777214474 @default.
• W3130217340 hasConcept C2778019345 @default.
• W3130217340 hasConcept C2780496750 @default.
• W3130217340 hasConcept C61511704 @default.
• W3130217340 hasConcept C71924100 @default.
• W3130217340 hasConcept C90924648 @default.
• W3130217340 hasConceptScore W3130217340C120665830 @default.
• W3130217340 hasConceptScore W3130217340C121332964 @default.
• W3130217340 hasConceptScore W3130217340C121608353 @default.
• W3130217340 hasConceptScore W3130217340C126322002 @default.
• W3130217340 hasConceptScore W3130217340C2777214474 @default.
• W3130217340 hasConceptScore W3130217340C2778019345 @default.
• W3130217340 hasConceptScore W3130217340C2780496750 @default.
• W3130217340 hasConceptScore W3130217340C61511704 @default.
• W3130217340 hasConceptScore W3130217340C71924100 @default.
• W3130217340 hasConceptScore W3130217340C90924648 @default.

• next